People

Inhaled pharmaceutical company Prosonix has hired Cécile Miles as its Chief Business Officer. She had been Commercial Director, Europe for the Arrow Group, part of Watson (now Actavis) since May 2011. Prior to Arrow, she had worked in various capacities at Ark Therapeutics, PLIVA, Ranbaxy, and Fisons. Miles said, "I am very excited to be joining the Prosonix team … [Read more...] about Prosonix names Cécile Miles as Chief Business Officer

Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously … [Read more...] about Pearl Therapeutics hires Michael Riebe

Discovery Laboratories has named John G. Cooper as President and CEO replacing W. Thomas Amick, who had been chairman of the board since March 2007 and CEO since October 2010. Cooper was Executive VP and CFO from 2002-2010 and has served as President and CFO since in 2010. He will continue as CFO. The company has also appointed John R. Leone chairman of the board … [Read more...] about New CEO, board appointments for Discovery Labs

Trimel Pharmaceuticals has named Tom Rossi as CEO to replace Bruce D. Brydon, who has stepped down as CEO. Rossi has been President of Trimel since he joined the company in August 2011 and also became Chief Operating Officer in March 2012. Brydon, who will continue as chairman of the board of directors, commented, "After 18 months as a reporting issuer on the … [Read more...] about Trimel names Tom Rossi new CEO

Alexza Pharmaceuticals has announced the appointment of J. Kevin Buchi to its board of directors. Buchi, who was Corporate Vice President, Global Branded Products at Teva Pharmaceutical Industries from October 2011 until May 2012, has over 30 years of experience in the pharmaceutical industry. Alexza's Adasuve loxapine inhalation powder for the treatment of … [Read more...] about Alexza appoints J. Kevin Buchi to board of directors

Paul M. Young and Daniela Traini have moved from the Pharmacy Faculty at the University of Sydney to the Woolcock Institute of Medical Research (WIMR) in order to establish a new Respiratory Technology team at the Institute. According to Young and Traini, "The WIMR is a world leading respiratory and sleep research organization whose aim is to foster, develop and … [Read more...] about Paul Young and Daniela Traini head up new Respiratory Technology Group

Prosonix has announced that Ken Cunningham will replace Jim Philips as Non-executive Chairman. Cunningham, who is also Chair of the company's scientific advisory board, is a former CEO of Skyepharma. He has been a member of the board of Prosonix since September 2011. Phillips, who is retiring from the board of directors, said, “After five years chairing Prosonix … [Read more...] about Ken Cunningham new Non-executive Chairman of Prosonix

OINDP component manufacturer Presspart has announced the appointment of Ameet Sule as Director of its new Inhalation Product Technology Centre (IPTC) in Blackburn, UK. Sule, who was most recently Director of Pulmonary Research at Lupin, will head the IPTC beginning January 15, 2013. He has almost 20 years of experience with respiratory delivery devices, formulations, … [Read more...] about Presspart hires Ameet Sule to head its Inhalation Product Technology Centre